iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Miracle Mile Advisors LLC

Miracle Mile Advisors LLC increased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 28.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 21,475 shares of the financial services provider’s stock after purchasing an additional 4,782 shares during the quarter. Miracle Mile Advisors LLC’s holdings in iShares Biotechnology ETF were worth $2,839,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. PVG Asset Management Corp purchased a new stake in iShares Biotechnology ETF during the second quarter worth approximately $415,000. Huntington National Bank increased its holdings in iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after purchasing an additional 160 shares in the last quarter. National Bank of Canada FI raised its position in iShares Biotechnology ETF by 5.9% in the third quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after purchasing an additional 229 shares during the period. First Financial Bank Trust Division acquired a new position in shares of iShares Biotechnology ETF during the third quarter worth about $204,000. Finally, Thrive Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the third quarter worth about $445,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.0 %

IBB stock opened at $134.02 on Tuesday. The stock has a 50-day simple moving average of $137.95 and a 200-day simple moving average of $141.99. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.